Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Purinergic receptor P2X 6 pseudogene (P2RX6P) is a human pseudogene located on chromosome 22. It is homologous to the purinergic receptor P2X 6 gene (P2RX6), which is part of the family of ATP-gated ion channels, but P2RX6P itself does not encode a functional protein. It is annotated and approved as a pseudogene by the HUGO Gene Nomenclature Committee. No functional protein, biological role, or disease association is currently established for P2RX6P, and it is not recognized as a therapeutic target in drug development. Any inclusion of P2RX6P as a target for pharmacological studies should be carefully checked, as its pseudogene status means it does not encode a therapeutic or biomarker protein.
None relevant; no mechanism of action as a drug target due to lack of a functional protein product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Purinergic receptor P2X 6 pseudogene (P2RX6P).